Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
30,074,835
-
Share change
-
+7,145,295
-
Total reported value
-
$572,957,619
-
Price per share
-
$19.57
-
Number of holders
-
86
-
Value change
-
+$138,404,989
-
Number of buys
-
69
-
Number of sells
-
15
Institutional Holders of HOMOLOGY MEDICINES INC - COM (FIXX) as of Q2 2019
As of 30 Jun 2019,
HOMOLOGY MEDICINES INC - COM (FIXX) was held by
86 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
30,074,835 shares.
The largest 10 holders included
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), Temasek Holdings (Private) Ltd, FMR LLC, BlackRock Inc., RTW INVESTMENTS, LP, JPMORGAN CHASE & CO, PRICE T ROWE ASSOCIATES INC /MD/, Bellevue Group AG, Vivo Capital, LLC, and VANGUARD GROUP INC.
This page lists
86
institutional shareholders reporting positions in this security
for the Q2 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.